microRNAs in colon cancer: a roadmap for discovery

FEBS Lett. 2012 Sep 21;586(19):3000-7. doi: 10.1016/j.febslet.2012.07.048.


Cancer omics data are exponentially created and associated with clinical variables, and important findings can be extracted based on bioinformatics approaches which can then be experimentally validated. Many of these findings are related to a specific class of non-coding RNA molecules called microRNAs (miRNAs) (post-transcriptional regulators of mRNA expression). The related research field is quite heterogeneous and bioinformaticians, clinicians, statisticians and biologists, as well as data miners and engineers collaborate to cure stored data and on new impulses coming from the output of the latest Next Generation Sequencing technologies. Here we review the main research findings on miRNA of the first 10 years in colon cancer research with an emphasis on possible uses in clinical practice. This review intends to provide a road map in the jungle of publications of miRNA in colorectal cancer, focusing on data availability and new ways to generate biologically relevant information out of these huge amounts of data.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / genetics
  • Colonic Neoplasms / diagnosis
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / therapy
  • Colorectal Neoplasms / genetics
  • Computational Biology
  • Humans
  • MicroRNAs / genetics*
  • Molecular Targeted Therapy
  • Prognosis
  • RNA, Neoplasm / genetics*


  • Biomarkers, Tumor
  • MicroRNAs
  • RNA, Neoplasm